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Abstract
Introduction: The purpose of the present review is to review our
experience with near-infrared spectroscopy (NIRS) monitoring in
shock resuscitation and predicting clinical outcomes.
Methods:  The management of critically ill patients with goal-
oriented intensive care unit (ICU) resuscitation continues to evolve
as our understanding of the appropriate physiologic targets improves.
It is now recognized that resuscitation to achieve supranormal
indices is not beneficial in all patients and may precipitate
abdominal compartment syndrome.
Results: Over the years, ICU technology has provided physicians
with specific physiologic parameters to guide shock resuscitation.
Throughout this time, the tissue hemoglobin oxygen saturation
(StO2) monitor has emerged as a non-invasive means to obtain
reliable physiologic parameters to guide clinicians’ resuscitative
efforts. StO2 monitors have been shown to aid in early
identification of nonresponders and to predict outcomes in
hemorrhagic shock and ICU resuscitation. These data have also
been used to better understand and refine existing resuscitation
protocols. More recently, use of NIRS technology to guide
resuscitation in septic shock has been shown to predict outcomes
in high-risk patients.
Conclusions:  StO2 is an important tool in identifying high-risk
patients in septic and hemorrhagic shock. It is a non-invasive
means of obtaining vital information regarding outcome and
adequacy of resuscitation.
Introduction
Near-infrared spectroscopy (NIRS) offers a new monitoring
tool to be used in critically ill patients. NIRS measures the
saturation of hemoglobin in the skeletal muscle and serves as
an index of perfusion. We have studied the value of tissue
hemoglobin oxygen saturation (StO2) in a number of settings,
including intensive care unit (ICU) shock resuscitation,
predicting outcomes in the emergency department (ED), and
to better understand massive transfusion (MT). The present
article will briefly review these experiences.
Intensive care unit traumatic shock
resuscitation
In the 1980s William Shoemaker and colleagues wrote a
series of papers addressing the use of physiologic monitoring
to predict outcome and to assist in clinical decision-making
[1-3]. Two interesting variables identified were oxygen
delivery (DO2) and oxygen consumption. In one observational
study, Shoemaker and colleagues tracked these variables in
preoperative and postoperative periods of high-risk patients
undergoing elective surgical procedures. In the preoperative
period, normal DO2 is 450 ml/min/m2 [1]. Following operative
intervention, survivors will increase their DO2 to above
600 ml/min/m2 [1]. Nonsurvivors attempt to achieve this
similar hyperdynamic state but cannot sustain it. Similarly,
normal oxygen consumption is approximately 120 ml/min/m2;
following an operation, survivors increase their oxygen
consumption to supernormal levels of above 150 ml/min/m2.
Likewise, nonsurvivors attempt to increase their oxygen
consumption in this range but are not able to achieve it.
Based on these observations, Shoemaker and colleagues
concluded that survivor parameters include cardiac index
>4.5 l/min/m2, DO2 >600 ml/min/m2, and oxygen consump-
tion >150 ml/min/m2 [1]. They proposed that the survivor
parameters should be adopted as resuscitation goals and
popularized the term supranormal oxygen delivery.
In the late 1980s Shoemaker and colleagues published the
results of a prospective trial where there were three study
groups who were managed by three different strategies [2].
The first group received a central venous line, and central
venous pressures were used at the discretion of clinicians to
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guide resuscitation. Pulmonary artery (PA) catheters were
placed in the second group, and monitored variables (PA
wedge pressure and cardiac index) were again used at the
clinicians’ discretion to direct resuscitation. PA catheters
were also placed in the third group of patients; however,
these patients were managed with a resuscitative protocol
that emphasized early volume loading followed by inotropic
support with dobutamine. The results of this trial showed a
dramatic reduction in mortality from 23% and 35% down to
4% between the central venous pressure and PA control
groups and the PA protocol-treated group, respectively [2].
Based on these observations and others, Shoemaker and
colleagues proposed that unrecognized flow-dependent
oxygen consumption contributed to the development of
multiple organ failure (MOF) [2,3]. At this time, MOF was the
leading cause of late ICU deaths and its pathophysiology was
unclear. This theory attributed myocardial dysfunction that
occurs in patients in shock as an important cause of subse-
quent MOF. This concept that unrecognized flow-dependent
oxygen consumption could be corrected by maximizing DO2
became a popular strategy.
Meanwhile, new technology was being introduced into the
ICU – including continuous venous oximetry and continuous
cardiac output monitoring with PA catheters [4]. This
permitted widespread use of oxygen transport variables to
guide resuscitation. At the Denver General Hospital in the
early 1990s, surgical intensivists developed a bedside clinical
protocol that involved identification of patients who were at
risk for postinjury MOF [5]. Upon arrival in the ICU, a PA
catheter was presumptively placed in high-risk patients and a
series of escalating interventions was utilized to maximize the
patient’s DO2. Based on the 12-hour response to these
interventions, the intensivists could predict who would
develop MOF.
A number of prospective randomized trials were performed in
the 1990s to test whether supernormal resuscitation truly
reduced mortality in critically ill patients [6]. The results of
these studies were varied and suggested that there are
subgroups of patients who do benefit from this strategy.
Benefits of hemodynamic optimization were most readily
observed in acutely ill patients who had not succumbed to
end-organ failure.
In the late 1990s at the University of Texas Houston Medical
School, a team of surgical intensivists collaborated with
bioengineers and health information experts to further refine
the logic for traumatic shock resuscitation and implemented it
with a computerized clinical decision support application [7].
Figure 1 represents an overview of this protocol. Patients
meeting specific criteria (evidence of major torso trauma,
evidence of shock as documented by base deficit >6 mEq,
and anticipated blood transfusions >6 units in 12 hours) had
PA and peripheral artery catheters inserted upon ICU arrival.
They were resuscitated to a DO2 goal of 600 ml/min/m2 with
a series of escalating interventions to achieve this goal in
nonresponders. This became the standard of care in the
shock trauma ICU at the Memorial Hermann Hospital in
Houston, Texas. The protocol provided a unique opportunity
to prospectively collect data on how patients responded to
interventions and to further refine the existing protocol to
optimize resuscitation.
This protocol also provided the opportunity to test the utility
of various monitors in this process of care. One such monitor
was StO2. To evaluate skeletal and subcutaneous StO2
changes as surrogates for DO2I changes and to compare
these variables with other commonly used indices of shock
resuscitation, we conducted a prospective study using StO2
monitors in shock resuscitation [8]. Figure 2a,b represents
the variables tracked over the first 24 hours of ICU admission.
These included StO2 at 6 mm (subcutaneous), StO2 at
20 mm (skeletal muscle), mixed venous hemoglobin oxygen
saturation (SvO2) (derived from the PA catheter), and serial
lactate levels and base deficit levels (both obtained from
serial blood testing). These variables were monitored
simultaneously in severely injured patients undergoing
protocol-directed shock resuscitation. Upon arrival in the ICU,
DO2 averaged approximately 400 ml/min/m2 and was driven
by the protocol intensivists to a maximum of roughly
700 ml/min/m2 by 24 hours. Throughout this resuscitation,
skeletal muscle StO2 (at 20 mm) appears to be quite
responsive to changes in systemic DO2. Changes in DO2
resulted in a predictable decrease in lactate and base deficit
levels, signifying effective shock resuscitation. Subcutaneous
StO2 (at 6 mm) was generally unresponsive to the
resuscitation intervention, while SvO2 derived from the PA
catheter shows only a small rise from roughly 70 to 78%
during the resuscitation process. Changes in StO2 (20 mm)
showed a strong correlation with changes in DO2, base
deficit, and lactate (r = 0.95 vs. 0.83 vs. 0.82, respectively)
but only modest correlation with SvO2 (r = 0.55).
The observation that the StO2 is an index of profusion that
tracks DO2 during active resuscitation led laboratory investi-
gators to investigate the role of StO2 monitors in the setting
of hemorrhagic shock. Greg Beilman and colleagues at the
University of Minnesota looked at the use of StO2 as an early
determinate of irreversible shock [9]. Monitored pigs were
subjected to a hemorrhagic shock protocol involving removal
of 35% of the pig’s blood volume over a 90-minute period.
Resuscitation was done in a stepwise fashion, with adminis-
tration of a 20 ml/kg bolus of lactated Ringer’s solution every
30 minutes, for a total of four boluses.
Eighteen out of 20 animals survived 90 minutes of hemor-
rhagic shock: 12 of the animals survived resuscitation
(resuscitatable) and six animals developed irreversible shock
(nonresuscitatable). Hemodynamic and NIRS measurements
were compared between the groups (resuscitatable vs.nonresuscitatable) at each step of resuscitation. All animals
had a decrease in cardiac output, SvO2 and DO2 and an
increase in lactate. A decrease in skeletal muscle, liver and
stomach StO2 was also observed. Beyond 30 minutes of
resuscitation, reversible shock patients were seen to have a
steady increase in cardiac output, while irreversible shock
patients demonstrated a steady decrease. More notably, the
drop in skeletal StO2 was significantly greater in animals who
did not survive resuscitation. Measurements of hind limb
StO2 in each group diverged within 30 minutes of shock,
such that by the end of the 90-minute period the StO2 value
for the nonresuscitatable group remained low despite resus-
citation. Animals destined to survive shock and resuscitation
did not exhibit an irreversible decline in StO2. These findings
demonstrate skeletal StO2 as a reliable, non-invasive means
for early differentiation between resuscitatable and nonresus-
citatable animals.
Another investigative group from the University of Miami, led
by Stephen Cohn, was also interested in the use of non-
invasive StO2 to guide fluid resuscitation after traumatic
shock. They evaluated three resuscitative strategies in a
series of three in vivo hemorrhagic shock models with or
without a simultaneous penetrating femur injury [10]. After a
30-minute shock period, animals were randomized to receive
no resuscitation, to receive 15 ml/kg Hextend or to receive
shed blood + 20 ml/kg lactated Ringer’s solution. Serial
lactate levels and serial base deficit levels were used to
identify the best response to resuscitation. Of the three
interventions, Hextend had the best clearance of base deficit
and lactate levels over the ensuing 150 minutes of
observation. SvO2 (derived from an invasive PA catheter) also
identified colloid resuscitation with Hextend as an effective
resuscitative strategy within 30 minutes of resuscitation.
Similarly, hind limb StO2 (a non-invasive monitor) indicated
enhanced resuscitation in response to Hextend.
Taken together, these clinical and research data suggest that
StO2 (derived from a non-invasive monitor) could provide
information about the effectiveness of resuscitation equivalent
to that of an invasive PA catheter or serial blood draws to
measure base deficit or lactate levels.
Predicting outcomes
In the late 1980s, Jim Davis and his colleagues from San
Diego popularized early routine collection of the base deficit
in trauma patients to evaluate for possible shock and to guide
ensuing volume resuscitation [11]. In subsequent publica-
tions they demonstrated that the admission base deficit in
trauma patient predicts transfusion requirements, risk of
complications and mortality [12]. Interestingly, Sauaia and
colleagues – who were interested in identifying early
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Figure 1
Overview of the resuscitation protocol. ABG, arterial blood gas; art, arterial; BD, base deficit; CI, cardiac index; DO2, oxygen delivery; Hb,
hemoglobin; ICU, intensive care unit; LR, lactated Ringer’s solution; NG, nasogastric; PA, pulmonary artery; PCWP, pulmonary wedge pressure;
PRBC, packed red blood cells; PrCO2, regional carbon dioxide tension measured by gastric tonometry. Reproduced with permission from [7].predictors of postinjury MOF – identified the ED base deficit
as the earliest independent predictor of MOF [13]. This
observation was validated in a second study from the same
group published in the late 1990s [14]. These data indicated
that the initial shock insult in a trauma patient is an important
determinate of adverse outcomes, particularly the develop-
ment of MOF.
With this in mind, Cohn and colleagues decided to perform a
study using StO2 monitoring in the emergency room to
determine whether it could predict MOF [15]. They
performed a prospective observational study involving seven
US trauma centers over a 16-month time period, ending in
2006. They proposed that thenar StO2 and base deficit could
equally predict MOF and death in major torso trauma patients
presenting in shock. Entry criteria included major torso
trauma (excluding severe head injury), ED shock (systolic
blood pressure <90 mmHg or base deficit ≥6 mEq/l), and
requirement of a blood transfusion. The StO2 monitor was
placed within 30 minutes of arrival in patients meeting the
inclusion criteria. Data collection included demographics
(age, gender, mechanism injury, injury severity score (ISS)),
continuous StO2 monitoring for the first 24 hours and routine
shock and resuscitation parameters. They looked at MOF and
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Figure 2
Shock resuscitation variables during shock resuscitation (first 24 hours) and the following 12 hours. (a) Tissue hemoglobin oxygen saturation
(StO2), deltoid skeletal muscle and subcutaneous StO2 saturation, monitored non-invasively using a prototype near-infrared spectrometer
(Biospectrometer-NB Oximeter; Hutchinson Technology, Inc., Hutchinson, MN, USA). Do2I, systemic oxygen delivery index. (b) Mixed venous
hemoglobin oxygen saturation (SvO2) monitored invasively using a pulmonary artery catheter with fiberoptic oximetry capability. BD, base deficit;
lactate, serum lactate concentration. Reproduced with permission from [8].death as their primary outcomes. There were 381 study
patients enrolled, predominantly males, with a high ISS of
28 ± 15. Two-thirds of patients sustained blunt mechanism
injury, most arrived in severe shock as documented by
admission systolic blood pressure of 84 ± 22 mmHg, heart
rate of 120 ± 23 beats/minute and ED base deficit of
9 ± 5 mEq/l, and they received on average 8 ± 7 units of
packed red cells within the first 6 hours.
Figure 3a depicts the receiver operator curve for the ability of
StO2 base deficit and systolic blood pressure to predict the
MOF outcome. MOF occurred in 50 out of the 381 cases
and it appeared that StO2 performed equally as well as base
deficit and systolic blood pressure, with an area under the
curve of 0.66, 0.63 and 0.57, respectively. Figure 3b depicts
the receiver operator curve for the endpoint of death. There
were 55 deaths out of 381 study patients, and it appeared
that StO2 outperformed base deficit and systolic blood
pressure in predicting this outcome with an area under the
curve of 0.72 versus 0.67 versus 0.66, respectively [15].
When these data were presented at the 2006 annual
meeting of the American Association for the Surgery for
Trauma, one question asked was whether StO2 measure-
ments compared with lactate levels as a predictor of MOF
and mortality. With this question in mind, the study database
was re-analyzed to identify patients who had lactate and StO2
measured in the first hour [16]. In this subgroup analysis, 151
patients had a documented lactate level. Twenty-seven of
these patients developed MOF. The corresponding StO2
levels had a predictive power that was equivalent to lactate
levels, with an area under the curve of 0.64 versus 0.65,
respectively. Looking at death as a primary endpoint, 26
deaths occurred in this cohort and again StO2 as a predictor
outperformed lactate in predicting death, with an area under
the curve of 0.77 versus 0.71 [16].
From these data we conclude that StO2 obtained within the
first hour after ED admission is an equally reliable predictor of
adverse outcomes when compared with the more
conventionally used parameters of lactate and base deficit.
StO2, however, is obtained non-invasively and continuously.
This allows the clinician to quickly identify patients in shock,
who are at high risk for adverse outcomes and to assess
adequacy and response to resuscitation.
Improving the understanding of epidemiology
of massive transfusion
In the 1980s US trauma surgeons witnessed tremendous
advances in trauma care, including trauma system develop-
ment, advanced trauma life support, damage control
resuscitation and goal-orientated ICU resuscitation. With
these advances in trauma care, there was a reduction in
patients who bled to death on the operating room table. The
cohort of patients with severe bleeding who survived long
enough to be admitted into an ICU, however, were at high
risk of developing abdominal compartment syndrome (ACS),
which emerged in epidemic proportions in the mid 1990s.
To better understand this new syndrome, Zsolt Balogh (a
visiting research fellow and Hungarian trauma surgeon)
analyzed the prospective shock resuscitation database that
was maintained by the University of Texas at Houston trauma
research center. He performed a series of four database
analyses that tremendously improved our understanding of
the pathophysiology of ACS and its relationship to MOF
[17-21]. Using prediction models, Balogh could accurately
predict who was going to develop ACS within 3 hours of
arriving in the ED. He showed that conventional use of high-
volume isotonic crystalloids to normalize blood pressure in
the ED were harmful to this subgroup of patients, leading to
hemodilution and promoting further bleeding. Once these
high-risk patients arrive in the ICU, they have significant intra-
abdominal hypertension – with mean urinary bladder
pressures ≥19 mmHg.
A popular belief at the time was that patients with high intra-
abdominal pressure (which falsely elevates central venous
pressure) and low cardiac output should be volume loaded to
increase preload and thereby optimize cardiac output.
Balogh’s studies, however, nicely demonstrated this is exactly
the wrong thing to do in patients with impending ACS. These
patients have low cardiac output and high systemic vascular
resistance. Additional increases in pre-load with isotonic
crystalloid boluses do not increase cardiac output; instead,
vigorous volume loading pushes them into full-blown ACS.
Balogh also demonstrated that reducing the DO2 goal of the
ICU resuscitation protocol from a supranormal level of
600 ml/min/m2 to a more normal level of 500 ml/min/m2 was
associated with a significant reduction in the incidence of
ACS, MOF and death. From these data it was concluded that
ACS was the result of early (in the ED) administration of
inordinate amounts of crystalloids and that fundamental
changes in the early care of patients with severe hemorrhage
were necessary.
Trauma surgeons at the University of Texas at Houston and
the Memorial Hermann Hospital then focused their efforts on
developing new pre-ICU care protocols, including ED
resuscitation, a MT protocol, whole-body CT scanning, a
pelvic fracture protocol, and the Focused Assessment with
Sonography for Trauma (FAST) examination with backup
peritoneal aspirate. Out of these protocols, the most
significant impact on patient outcome was presented with the
MT protocol. Gonzalez and colleagues performed a
retrospective analysis of the shock resuscitation database to
evaluate the existing MT protocol. MT was defined as
>10 units of packed red blood cells in 24 hours [22]. This
analysis identified that patients arrived in the ICU with
irreversible coagulopathy despite adherence to the existing
MT protocol. This coagulopathy persisted as the patient went
on to require substantial blood transfusion. The admission
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subsequent mortality, and the investigators concluded that
fresh frozen plasma should be used earlier and more
aggressively in the ED for patients that required a MT. They
proposed that fresh frozen plasma (FFP) and packed red
blood cells be used at a ratio of 1:1.
John Holcomb, who developed the original MT protocol at
Memorial Hermann Hospital, was also an advocate for the
use of activated factor VII in damage-control patients [23],
and subsequently further expanded this concept when he
became the Commander of the US Army Institute of Surgical
Research in San Antonio. He and his colleagues developed a
new concept of damage control resuscitation, which empha-
sizes direct treatment of coagulopathy in trauma during initial
resuscitative efforts [24]. The primary goals of this strategy
were early use of FFP, activated recombinant factor VII and
fresh whole blood when available and to pursue hypotensive
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Figure 3
Physiologic parameters relative to multiple organ dysfunction syndrome and mortality. Receiver operating characteristic curves for physiologic
parameters relative to (a) multiple organ dysfunction syndrome and (b) mortality within 1 hour of emergency department arrival. Skeletal muscle
tissue hemoglobin saturation (StO2) monitored non-invasively using a prototype near-infrared spectrometer (InSpectra Tissue Spectrometer;
Hutchinson Technology, Inc., Hutchinson, MN, USA). BD, base deficit; SBP, systolic blood pressure. Reproduced with permission from [15].resuscitation until hemorrhage is definitively controlled. This
concept has been used in the current conflicts in Afghanistan
and Iraq. The data emerging from those conflicts suggest that
this approach reduces mortality in patients sustaining serious
torso and limb trauma.
While these strategies are all very enticing, a central question
emerged when faced with the clinical quandary of a patient
with an unstable pelvic fracture who is in obvious shock: how
much time does the clinician have to make these critical
decisions? When do you initiate aggressive FFP adminis-
tration or administer factor VII? After initial resuscitation, does
the clinician triage the patient to the CT scanner, to the
operating room or wait for the angiographers to come in to
embolize potential pelvic bleeder? To answer these ques-
tions, a retrospective analysis of the StO2 database was
conducted [25]. The specific aims of the analysis were: to
define the current epidemiology of MT, which includes
documenting early temporal events and confirming the
association of MT with bad outcomes, including MOF and
death; and, secondly, to determine feasibility of the early
prediction of MT and the potential role of StO2 in these
prediction models.
In this 16-month observational study, there were 381 patients
who met entry criteria; 114 (30%) received MT (defined as
>10 units in the first 24 hours). The MT cohort versus the
non-MT cohort had similar demographics, but the patients
who received a MT had a notably higher ISS (32 ± 17 vs.
26 ± 15). Analysis of the data also showed that the MT
patients arrived hypothermic, were in severe shock and were
notably coagulopathic. Their initial International Normalized
Ratio was 1.7 ± 1.4. Comparing baseline characteristics
between the two cohorts, all variables with the exception of
temperature were significantly less deranged in the non-MT
cohort. These data demonstrated that, upon arrival, MT
patients are different from non-MT patients. They have higher
ISS, they have more severe shock and they are severely
coagulopathic prior to aggressive inhospital resuscitation.
Most notably, MT is a very rapid process of care; 40% of the
patients met the threshold of 10 units within 2 hours and
80% met the threshold within 6 hours. By 6 hours the MT
cohort had received on average 20 units of packed red blood
cells. Looking at time to death in the first 24 hours, there were
26 early deaths in the MT cohort, of which two-thirds
occurred within the first 6 hours. These data emphasize that
critical decisions must be made in a limited amount of time.
Assessment of clinical outcomes such as ICU-free days, vent-
free days, hospital days, and percentages of death and MOF
showed that MT patients have longer ICU stays and spend
more time on mechanical ventilators. The mortality rate for MT
patients was 33%; the incidence of MOF was 31%, and 50%
of patients had the combined outcome of MOF and death.
When you compare these outcomes with the non-MT
patients, it is clear that MT patients have much worse
outcomes. We were also interested in identifying the early
predictors of bad outcome (MOF/death). Using univariate
analysis comparing good outcome versus bad outcome, a
number of variables were identified. We then chose P <0.15
between the two groups to identify variables to be placed
into three multivariate models using data available 1 hour,
2 hours and 3 hours after their trauma center arrival [26]. The
purpose of this analysis was to identify a specific variable that
could help the clinicians make critical decisions. More
specifically, for patients in whom it is decided to initiate a MT,
to determine which variables would tell you that a specific
patient was at high risk of dying and therefore would warrant
the use of a potentially harmful intervention such as activated
factor VIIa. In the 1-hour, 2-hour and 3-hour models two
variables fell out: injury severity score >25 at 1 hour and
2 hours, and the StO2 value in the 1-hour, 2-hour and 3-hour
models. StO2 is therefore a good variable to help identify the
patient who is going to die.
Given the amount of controversy that currently exists over the
management of MT and the need for a clinical trial to address
the potential role of aggressive early FFP analysis, we
performed a second follow-up analysis of the StO2 database
with a focused study on the “MT died early” cohort [26]. We
looked at the 114 patients who received a MT and divided
them into three groups: G1 was the 27 early deaths, G2
included 31 patients who developed MOF or died late, and
G3 was the remaining 50 patients who had a MT but did not
die.
Looking at the number of packed red blood cells over the first
6 hours for the various groups, the G1 MT died early group
received 26.4 units of packed red blood cells but only
6.5 units of FFP. Considering the bloody vicious cycle patho-
physiology and comparing the three groups for temperature,
acidosis and coagulopathy, the G1 group had more
deranged physiology. This group was severely acidotic and
coagulopathic in comparison with G2 and G3. Interestingly,
the coagulopathy in G1 was noted to worsen over the first
3 hours; the MT died early patients arrived with a significantly
higher International Normalized Ratio of 2.4, which increased
to 3.8. Consequently, approximately 70% of these patients
bled to death during a time period corresponding to their
worsening coagulopathy [26]. From these data we conclude
that this subgroup of patients arrived with coagulopathy,
received an ordinary amount of packed red blood cells (that
is, 26.4 units) but received only 6.5 units of FFP, and there-
fore their coagulopathy was not treated.
When we look at the shock parameters (Figure 4) of systolic
blood pressure, base deficit and StO2, the major observation
is that StO2 is very different in this cohort of patients who
were dying early. StO2 measurements dropped steadily from
70 to 50% as they died early from exsanguination. We
therefore concluded that, in the setting of MT, a dropping
StO2 portends early death from exsanguination.
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In our ongoing experience, NIRS or StO2 monitoring offers a
continuous non-invasive monitor of hypoperfusion. In early
clinical testing during active shock resuscitation, changes in
skeletal muscle StO2 correlated well with changes in DO2,
base deficit and lactate levels. This clinical experience in
active shock resuscitation has likewise been verified in
laboratory studies. In a prospective clinical trial of StO2
monitoring obtained within the first hour after ED admission
of major torso trauma patients who were presumed to be
bleeding, the StO2 value predicted death and MOF as well as
or perhaps better than base deficit and lactate levels [15].
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Figure 4
Shock indices over the first 6 hours of hospitalization. G1, massive transfusion (MT) and dies in ≤24 hours; G2, MT and dies in >24 hours and/or
multiple organ failure (MOF); G3, MT and survived without MOF. P-values reported for the group and hour from trauma center (TC) arrival factor
and the interaction term. SBP, systolic blood pressure; StO2, tissue hemoglobin oxygen saturation. Reproduced with permission from [26].Additionally, in the setting of MT we observed that a drop in
StO2 portends early death from exsanguination [25,26] and
may be helpful in making critical decisions.
Competing interests
FAM is a member of the Hutchinson Technology Inc. Trauma
and Critical Care Advisory Board. RJS declares that they
have no competing interests.
Acknowledgement
This article is part of Critical Care Volume 13 Supplement 5: Tissue
oxygenation (StO2) in healthy volunteers and critically-ill patients. The
full contents of the supplement are available online at http://ccforum.
com/supplements/13/S5. Publication of the supplement has been sup-
ported with funding from Hutchinson Technology Inc.
References
1. Shoemaker WC, Appel P, Bland R: Use of physiologic monitor-
ing to predict outcome and to assist in clinical decisions in
critically ill postoperative patients. Am J Surg 1983, 146:43-50.
2. Shoemaker WC, Appel PL, Kram HB, Waxman K, Lee TS:
Prospective trial of supranormal values survivors as thera-
peutic goals in high risk surgical patients. Chest 1988,  94:
1176-1183.
3. Shoemaker WC: Invasive and noninvasive hemodynamic mon-
itoring of high-risk patients to improve outcome. Semin
Anesth Periop Med Pain 1999, 18:63-70.
4. Nelson L: Continous venous oximetry in surgical patients. Ann
Surg 1986, 203:329-333.
5. Moore FA, Haenal J, Moore E, Whitehall T: Incommensurate
oxygen consumption in response to maximal oxygen avail-
ability predicts postinjury multiple organ failure. J Trauma
1992, 33:58-65.
6. Kern JW, Shoemaker WC: Meta-analysis of hemodynamic opti-
mization in high risk patients. Crit Care Med 2002, 30:1686-
1692.
7. Moore FA: Evidence-based medical information technology:
the next generation. J Trauma 2007, 63:1195-1205.
8. McKinley BA, Marvin R, Coconour CS, Moore FA: Tissue hemo-
globin O2 saturation during resuscitation of traumatic shock
monitored by using near infrared spectrometry. J Trauma
2000, 48:637-642.
9. Taylor JH, Mulier KE, Myers DE, Beilman GJ: Use of near infrared
spectroscopy in early determination of irreversible hemor-
rhagic shock. J Trauma 2005, 58:1119-1125.
10. Crookes BA, Cohn SM, Burton EA, Nelson J, Proctor KG: Nonin-
vasive muscle oxygenation to guide fluid resuscitation after
shock. Surgery 2004, 135:662-670.
11. Davis J, Shckford SR, Mackersie RC, Hoyt DB: Base deficit as a
guide to volume resuscitation. J Trauma 1988, 28:1464-1467.
12. Davis JW, Parks SN, Kaups KL, Gladen HE, O’Donnell-Nicol S:
Admission base deficit predicts transfusion requirements and
risk of complications. J Trauma 1996, 41:769-774.
13. Sauaia A, Moore FA, Moore EE, Haenal JB, Read RA, Lezotte DC:
Early predictors of postinjury multiple organ failure. Arch Surg
1994, 129:39-45.
14. Sauaia A, Moore FA, Moore EE, Norris JM, Lezotte DC: Multiple
organ failure can be predicted as early as 12 hours after
injury. J Trauma 1998, 45:291-301.
15. Cohn SM, Nathens AB, Moore FA, Rhee P, Puyana JC, Moore EE,
Beilman GJ, and the StO2 in Trauma Patients Trail Investigators:
Tissue oxygen saturation predicts the development of organ
dysfunction during traumatic shock resuscitation. J Trauma
2007, 62:44-55.
16. Moore FA: Tissue oxygen saturation predicts the development of
organ failure during traumatic shock resuscitation. In International
Proceedings of the 7th World Congress on Trauma, Shock,
Inflammation and Sepsis; 13–17 March 2007; Munich, Germany.
Edited by E Faist. Bologna, Italy: Medimond; 2007:111-114.
17. Zsolt B, McKinley BA, Coconour CS, Kozar RA, Holcomb J, Ware
D, Moore FA: Secondary abdominal compartment syndrome is
an elusive early complication of shock resuscitation. Am J
Surg 2002, 184:538-543.
18. Zsolt B, McKinley BA, Holcomb J, Miller CC, Coconour CS, Kozar
RA, Valdivia A, Ware DN, Moore FA: Both primary and sec-
ondary abdominal compartment syndrome can be predicted
early and harbingers of multiple organ failure. J Trauma 2003,
54:848-861.
19. Zsolt B, McKinley BA, Coconour CS, Kozar RA, Cox C, Moore FA:
Patients with impending abdominal compartment syndrome
do not respond to early volume loading. Am J Surg 2003, 186:
602-607.
20. Zsolt B, McKinley BA, Coconour CS, Kozar RA, Valdivia A, Sailors
M, Moore FA: Supranormal trauma resuscitation causes more
cases of abdominal compartment syndrome. Arch Surg 2003,
138:637-642.
21. Zsolt B, McKinley BA, Cox C, Allen SJ, Coconour CS, Kozar RA,
Moore EE, Miller CC, Weisbrodt NW, Moore FA: Abdominal
compartment syndrome: the cause of effect of postinjury mul-
tiple organ failure. Shock 2003, 20:483-492.
22. Gonzalez EA, Moore FA, Holcomb JB, Miller CC, Kozar RA, Todd
SR, Cocanour CS, Balldin BC, McKinley BA: Fresh frozen
plasma should be given earlier to patients requiring massive
transfusion. J Trauma 2007, 62:112-119.
23. Holcomb JB, Hoots WK, Moore FA: Treatment of an acquired
coagulopathy with recombinant activated factor VII in a
damage-control patient. Mil Med 2005, 170:287-290.
24. Holcomb JB, Jenkins D, Rhee P, Johannigman J, Mahoney P,
Mehta S, Cox ED, Gehrke MJ, Beilman GJ, Schreiber M, Flaherty
SF, Grathwohl KW, Spinella PC, Perkins JG, Beekley AC,
McMullin NR, Park MS, Gonzalez EA, Wade CE, Dubick MA,
Schwab CW, Moore FA, Champion HR, Hoyt DB, Hess JR:
Damage control resuscitation: directly addressing the early
coagulopathy of trauma. J Trauma 2007, 62:307-310.
25. Moore FA, Nelson T, McKinley BA, Moore EE, Nathen AB, Rhee
P, Puyana JC, Beilman GJ, Cohn SM, and the StO2 Study Group:
Massive transfusion in trauma patients: tissue hemoglobin
oxygen saturation predicts bad outcomes. J Trauma 2008, 64:
1010-1023.
26. Moore FA, Nelson T, McKinley BA, Moore EE, Nathen AB, Rhee
P, Puyana JC, Beilman GJ, Cohn SM, and the StO2 Study Group:
Is there a role for aggressive use of fresh frozen plasma in
massive transfusion of civilian trauma patients. Am J Surg
2008, 196:948-960.
Available online http://ccforum.com/content/13/S5/S10
Page 9 of 9
(page number not for citation purposes)